CaliPharms, Inc. (KGET)

CaliPharms Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2014	Dec 31, 2013	Dec 31, 2012	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010
Cash & Equivalents	0.02	-	-	-	0	-
Cash & Short-Term Investments	0.02	-	-	-	0	-
Other Current Assets	-	-	-	-	0	0
Total Current Assets	0.02	-	-	-	0	0
Property, Plant & Equipment	-	-	-	2	-	-
Long-Term Investments	-	-	-	1	1	1
Other Intangible Assets	-	-	-	1.57	1.57	-
Other Long-Term Assets	-	-	-	-	0.01	0.01
Total Assets	0.02	-	-	4.57	2.58	1.02
Accounts Payable	1.76	1.76	1.84	3.54	2.66	0.49
Accrued Expenses	0.24	-	-	-	-	-
Short-Term Debt	0.22	0.67	0.62	2.99	1.17	0.83
Current Portion of Long-Term Debt	-	-	-	0.08	3.68	3.68
Other Current Liabilities	6.59	-	-	2.37	9.53	9.13
Total Current Liabilities	8.81	2.43	2.46	8.98	17.03	14.12
Total Liabilities	8.81	2.43	2.46	8.98	17.03	14.12
Common Stock	0	0.1	0.02	0.01	0	0
Additional Paid-In Capital	25.15	24.63	24.46	22.67	11.62	21.54
Retained Earnings	-33.94	-27.06	-26.84	-26.99	-25.97	-34.54
Treasury Stock	-	-0.1	-0.1	-0.1	-0.1	-0.1
Total Common Equity	-8.79	-2.43	-2.46	-4.41	-14.44	-13.11
Shareholders' Equity	-8.79	-2.43	-2.46	-4.41	-14.44	-13.11
Total Liabilities & Equity	0.02	-	-	4.57	2.58	1.02
Total Debt	0.22	0.67	0.62	3.07	4.85	4.51
Net Cash (Debt)	-0.21	-0.67	-0.62	-3.07	-4.85	-4.51
Net Cash Per Share	-0.00	-0.02	-0.06	-0.73	-1.53	-2.77
Filing Date Shares Outstanding	4,013	3,058	18.2	8.9	3.88	1.97
Total Common Shares Outstanding	3,363	96.3	18.2	8.9	3.88	1.97
Working Capital	-8.79	-2.43	-2.46	-8.98	-17.02	-14.12
Book Value Per Share	-0.00	-0.03	-0.13	-0.50	-3.72	-6.64
Tangible Book Value	-8.79	-2.43	-2.46	-5.98	-16.01	-13.11
Tangible Book Value Per Share	-0.00	-0.03	-0.13	-0.67	-4.13	-6.64
Land	-	-	-	2	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.